IMMP Immutep Limited ADRs

Immutep Ltd, formerly Prima Biomed Ltd is a biotechnology company. It is engaged in the development of immunotherapeutic products for cancer and autoimmune disease. Their operations are based in Australia and Europe. This is an ADR of a company whose stock trades outside of the U.S. as the symbol AT:IMM.

$3.51  -0.03 (-0.85%)
As of 04/09/2021 15:51:58 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Australia
Country of incorporation:  Australia
IPO date:  02/11/2013
Outstanding shares:  67,235,931
Average volume:  6,998,794
Market cap:   $237,342,836
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    45257L108
ISIN:        US45257L1089
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   4.97
PS ratio:   23.76
Return on equity:   -32.49%
Net income %:   -151.07%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy